Laboratory of Lymphocyte Signaling and Oncoproteome

Funding

Bundesministerium für Bildung und Forschung
CECAD
CMMC
Control-T
DFG
Deutsche Krebshilfe
ERA PER MED
Fritz Thyssen Stiftung
Käthe-Hack-Stiftung
Köln Fortune
Hochhaus-Stiftung
Horizon 2020
Jose Carreras Stiftung
Mundipharma
Nachlass Nolting
Roche
UK Köln

News

Future therapies in T-PLL and T-LGL

Future therapies in T-PLL and T-LGL

June 7, 2021

New perspective on future targeted therapy approaches published.

New article accepted for publication

New article accepted for publication

August 30, 2020

Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood

Alkylating deacetylase inhibitor tinostamustine in T-PLL

March 11, 2020

New letter evaluating the effects of EDO-S101/tinostamustine published in Leukemia.

Advances and Perspectives in the Treatment of T-PLL

Advances and Perspectives in the Treatment of T-PLL

February 25, 2020

New review on current and future strategies in treating T-PLL published in Current Hematologic Malignancy Reports